Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Clinical Trial on the Efficacy of a Probiotic Strain of Bifidobacterium Longum 35624 (Alflorex®) in Functional Gastrointestinal Disorders (GFRS) in Children 8 to 18 Years of Age.

NCT04922476 is registered in ClinicalTrials.gov with PrecisionBiotics Group Ltd. as lead sponsor.

NCT NCT04922476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04922476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Clinical Trial on the Efficacy of a Probiotic Strain of Bifidobacterium Longum 35624 (Alflorex®) in Functional Gastrointestinal Disorders (GFRS) in Children 8 to 18 Years of Age.
Lead sponsor
PrecisionBiotics Group Ltd.
Phase
Not applicable
Overall status
Completed
Start date
August 6, 2021
Completion date
April 4, 2023
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

functional abdominal pain, functional gastrointestinal disorders